Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, C-myc, Bcl-XL, NF-κB, and p53

被引:175
|
作者
Han, SS
Chung, ST
Robertson, DA
Ranjan, D
Bondada, S
机构
[1] Univ Kentucky, Dept Microbiol & Immunol, Lexington, KY 40536 USA
[2] Univ Kentucky, Sanders Brown Res Ctr Aging, Lexington, KY 40536 USA
[3] Univ Kentucky, Dept Gen Surg, Transplantat Sect, Lexington, KY 40536 USA
[4] Korea Food & Drug Adm, Div Immunotoxicol, Seoul 122020, South Korea
关键词
D O I
10.1006/clim.1999.4769
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It has been well known that curcumin is a powerful inhibitor of proliferation of several tumor cells. However, the molecular basis of the anti-proliferative effect of curcumin has not been investigated in detail. In this paper, we present evidence to show that curcumin inhibited proliferation of a variety of B lymphoma cells. At low concentrations curcumin inhibited the proliferation of BKS-2, an immature B cell lymphoma, more effectively than that of normal B lymphocytes and caused the apoptosis of BKS-2 cells in a dose- and time-dependent manner. Furthermore, curcumin downregulated the expression of survival genes egr-1, c-myc, and bcl-X-L as well as the tumor suppressor gene p53 in B cells. In addition, NF-kappa B binding activity was also downregulated almost completely by curcumin, Stimulation with CpG oligonucleotides or anti-CD40 overcame growth inhibition induced by low concentrations of curcumin, Our results suggest that curcumin caused the growth arrest and apoptosis of BKS-2 immature B cell lymphoma by downregulation of growth and survival promoting genes, (C) 1999 Academic Press.
引用
收藏
页码:152 / 161
页数:10
相关论文
共 50 条
  • [31] P53 MUTATIONS, C-MYC AND BCL-2 REARRANGEMENTS IN HUMAN NON-HODGKINS-LYMPHOMA CELL-LINES
    CHANG, H
    BLONDAL, JA
    BENCHIMOL, S
    MINDEN, MD
    MESSNER, HA
    LEUKEMIA & LYMPHOMA, 1995, 19 (1-2) : 165 - 171
  • [32] B cell growth is controlled by phosphatidylinosotol 3-kinase-dependent Rel/NF-κB regulated induction of c-myc transcription
    Grumont, RJ
    Strasser, A
    Gerondakis, S
    MOLECULAR CELL, 2002, 10 (06) : 1283 - 1294
  • [33] Case of B-Cell lymphoma with rearrangement of the BCL1, BCL2, BCL6, and c-MYC genes
    Kawakami, K
    Miyanishi, S
    Sonoki, T
    Nakamura, S
    Nomura, K
    Taniwaki, M
    Murata, T
    Kadowaki, S
    Kadowaki, N
    Miura, I
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 79 (05) : 474 - 479
  • [34] Case of B-Cell Lymphoma with Rearrangement of the BCL1, BCL2, BCL6, and c-MYC Genes
    Keiki Kawakami
    Setsuko Miyanishi
    Takashi Sonoki
    Shigeo Nakamura
    Kenichi Nomura
    Masafumi Taniwaki
    Tetsuya Murata
    Shigenori Kadowaki
    Norimitsu Kadowaki
    Ikuo Miura
    International Journal of Hematology, 2004, 79 : 474 - 479
  • [35] Expression of p53, bcl-2, bax, bcl-x2 and c-myc in radiation-induced apoptosis in Burkitt's lymphoma cells
    Khanna, KK
    Wie, T
    Song, QZ
    Burrows, SR
    Moss, DJ
    Krajewski, S
    Reed, JC
    Lavin, MF
    CELL DEATH AND DIFFERENTIATION, 1996, 3 (03): : 315 - 322
  • [36] Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-κB and inhibition of Bcl-xL expression
    Sara Huerta-Yepez
    Mario Vega
    Ali Jazirehi
    Hermes Garban
    Fumiya Hongo
    Genhong Cheng
    Benjamin Bonavida
    Oncogene, 2004, 23 : 4993 - 5003
  • [37] Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-κB and inhibition of Bcl-xL expression
    Huerta-Yepez, S
    Vega, M
    Jazirehi, A
    Garban, H
    Hongo, F
    Cheng, GH
    Bonavida, B
    ONCOGENE, 2004, 23 (29) : 4993 - 5003
  • [38] RelB-p50 NF-κB complexes are selectively induced by cytomegalovirus immediate-early protein 1:: Differential regulation of Bcl-xL promoter activity by NF-κB family members
    Jiang, HY
    Petrovas, C
    Sonenshein, GE
    JOURNAL OF VIROLOGY, 2002, 76 (11) : 5737 - 5747
  • [39] Large B Cell Lymphoma with MYC Rearrangement Is Associated with High P53 Expression and a Poor Prognosis Similar to MYC/BCL2 Double Hit Lymphoma
    Weiss, V. L.
    Wang, X. J.
    Medeiros, L. J.
    Li, S.
    MODERN PATHOLOGY, 2014, 27 : 385A - 385A
  • [40] Large B Cell Lymphoma with MYC Rearrangement Is Associated with High P53 Expression and a Poor Prognosis Similar to MYC/BCL2 Double Hit Lymphoma
    Weiss, V. L.
    Wang, X. J.
    Medeiros, L. J.
    Li, S.
    LABORATORY INVESTIGATION, 2014, 94 : 385A - 385A